111 related articles for article (PubMed ID: 25812367)
1. [Prandial glucose regulator and insulin secretagogue; glinide and its combination therapy].
Nakashima E
Nihon Rinsho; 2015 Mar; 73(3):416-23. PubMed ID: 25812367
[TBL] [Abstract][Full Text] [Related]
2. [Significance of insulin secretion pattern lectured by "glinides" in the treatment of postprandial hyperglycemia].
Hirose T
Nihon Rinsho; 2005 Dec; 63(12):2237-44. PubMed ID: 16363700
[TBL] [Abstract][Full Text] [Related]
3. [Glinide(s), sulfonylurea(s)].
Arakawa M; Hirose T
Nihon Rinsho; 2006 Nov; 64(11):2107-12. PubMed ID: 17087304
[TBL] [Abstract][Full Text] [Related]
4. Effect of combination therapy of a rapid-acting insulin secretagogue (glinide) with premixed insulin in type 2 diabetes mellitus.
Yamada S; Watanabe M; Funae O; Atsumi Y; Suzuki R; Yajima K; Nakamura Y; Kawai T; Oikawa Y; Shimada A
Intern Med; 2007; 46(23):1893-7. PubMed ID: 18057760
[TBL] [Abstract][Full Text] [Related]
5. [Nateglinide and mitiglinide].
Odawara M
Nihon Rinsho; 2003 Jul; 61(7):1230-7. PubMed ID: 12877090
[TBL] [Abstract][Full Text] [Related]
6. [Dangerous postprandial glucose peaks. Risk for heart and blood vessels].
MMW Fortschr Med; 2002 May; 144(21):58. PubMed ID: 12134432
[No Abstract] [Full Text] [Related]
7. [Pharmacological treatment of postprandial hyperglycemia in hypertensive patients with type 2 diabetes mellitus].
Yamada K
Nihon Rinsho; 2003 Jul; 61(7):1219-23. PubMed ID: 12877088
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of glinides.
Chen M; Hu C; Jia W
Pharmacogenomics; 2015 Jan; 16(1):45-60. PubMed ID: 25560470
[TBL] [Abstract][Full Text] [Related]
9. [Non-SU, insulin secretagogues].
Kikuchi M
Nihon Rinsho; 1999 Mar; 57(3):702-8. PubMed ID: 10199157
[TBL] [Abstract][Full Text] [Related]
10. [Fasting hyperglycemia and postprandial glucose peaks. Diabetes therapy mustact on 2 sides].
MMW Fortschr Med; 2003 Aug; 145(33-34):59. PubMed ID: 14526583
[No Abstract] [Full Text] [Related]
11. [Glinides and glitazones in diabetes treatment. Are they really effective?].
Parhofer KG; Göke B
MMW Fortschr Med; 2002 May; 144(18):34-6, 38-9. PubMed ID: 12422705
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of α-Glucosidase inhibitors and glinide drugs on endothelial dysfunction in diabetic patients with coronary artery disease.
Sawada T; Shiotani H; Terashita D; Nagasawa Y; Kim SS; Koide M; Yokoyama M
Circ J; 2014; 78(1):248-55. PubMed ID: 24225338
[TBL] [Abstract][Full Text] [Related]
13. [Sulfonylureas and glinides].
Kudo K; Hirose T
Nihon Rinsho; 2011 Jan; 69 Suppl 1():645-53. PubMed ID: 21766676
[No Abstract] [Full Text] [Related]
14. [Sulfonylureas and glinides].
Hirose T
Nihon Rinsho; 2006 Dec; 64 Suppl 9():646-53. PubMed ID: 17458297
[No Abstract] [Full Text] [Related]
15. Impairment of early insulin response after glucose load, rather than insulin resistance, is responsible for postprandial hyperglycemia seen in obese type 2 diabetes: assessment using nateglinide, a new insulin secretagogue.
Uchino H; Niwa M; Shimizu T; Nishiyama K; Kawamori R
Endocr J; 2000 Oct; 47(5):639-41. PubMed ID: 11200947
[TBL] [Abstract][Full Text] [Related]
16. Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes.
Carroll MF; Gutierrez A; Castro M; Tsewang D; Schade DS
J Clin Endocrinol Metab; 2003 Nov; 88(11):5248-54. PubMed ID: 14602757
[TBL] [Abstract][Full Text] [Related]
17. [Effects of nateglinide in impaired glucose tolerance subjects].
Hirose T
Nihon Rinsho; 2005 Feb; 63 Suppl 2():438-43. PubMed ID: 15779419
[No Abstract] [Full Text] [Related]
18. Nateglinide: a new rapid-acting insulinotropic agent.
Hanif W; Kumar S
Expert Opin Pharmacother; 2001 Jun; 2(6):1027-31. PubMed ID: 11585005
[TBL] [Abstract][Full Text] [Related]
19. Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.
Scheen AJ
Clin Pharmacokinet; 2007; 46(2):93-108. PubMed ID: 17253883
[TBL] [Abstract][Full Text] [Related]
20. Nateglinide may increase high-molecular weight adiponectin in type 2 diabetic patients with hypoadiponectinemia.
Iwase M; Iino K; Doi Y; Asano T; Iida M
Diabetes Res Clin Pract; 2008 Dec; 82(3):e19-22. PubMed ID: 18849086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
